GERN
Price
$1.35
Change
-$0.11 (-7.48%)
Updated
Apr 4, 03:47 PM (EDT)
Capitalization
1.01B
38 days until earnings call
VCYT
Price
$28.54
Change
+$0.06 (+0.21%)
Updated
Apr 4, 04:01 PM (EDT)
Capitalization
1.66B
39 days until earnings call
Ad is loading...

GERN vs VCYT

Header iconGERN vs VCYT Comparison
Open Charts GERN vs VCYTBanner chart's image
Geron
Price$1.35
Change-$0.11 (-7.48%)
Volume$52.5K
Capitalization1.01B
Veracyte
Price$28.54
Change+$0.06 (+0.21%)
Volume$800
Capitalization1.66B
GERN vs VCYT Comparison Chart
Loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GERN vs. VCYT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a Hold and VCYT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GERN: $1.47 vs. VCYT: $28.47)
Brand notoriety: GERN and VCYT are both not notable
GERN represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GERN: 62% vs. VCYT: 92%
Market capitalization -- GERN: $1.01B vs. VCYT: $1.66B
GERN [@Biotechnology] is valued at $1.01B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GERN’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • GERN’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • GERN’s TA Score: 5 bullish, 3 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GERN is a better buy in the short-term than VCYT.

Price Growth

GERN (@Biotechnology) experienced а -10.91% price change this week, while VCYT (@Medical Specialties) price change was -8.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.26%. For the same industry, the average monthly price growth was -17.11%, and the average quarterly price growth was -18.89%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.88%. For the same industry, the average monthly price growth was -2.35%, and the average quarterly price growth was -1.58%.

Reported Earning Dates

GERN is expected to report earnings on May 12, 2025.

VCYT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-11.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-5.88% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than GERN($1.01B). VCYT YTD gains are higher at: -28.106 vs. GERN (-58.475). VCYT has higher annual earnings (EBITDA): -49.41M vs. GERN (-154.85M). GERN has more cash in the bank: 407M vs. VCYT (216M). VCYT has less debt than GERN: VCYT (12.6M) vs GERN (122M). VCYT has higher revenues than GERN: VCYT (361M) vs GERN (77M).
GERNVCYTGERN / VCYT
Capitalization1.01B1.66B61%
EBITDA-154.85M-49.41M313%
Gain YTD-58.475-28.106208%
P/E RatioN/AN/A-
Revenue77M361M21%
Total Cash407M216M188%
Total Debt122M12.6M968%
FUNDAMENTALS RATINGS
GERN vs VCYT: Fundamental Ratings
GERN
VCYT
OUTLOOK RATING
1..100
724
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
8492
SMR RATING
1..100
9888
PRICE GROWTH RATING
1..100
9260
P/E GROWTH RATING
1..100
6662
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (81) in the Biotechnology industry is in the same range as GERN (92). This means that VCYT’s stock grew similarly to GERN’s over the last 12 months.

GERN's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as VCYT (92). This means that GERN’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's SMR Rating (88) in the Biotechnology industry is in the same range as GERN (98). This means that VCYT’s stock grew similarly to GERN’s over the last 12 months.

VCYT's Price Growth Rating (60) in the Biotechnology industry is in the same range as GERN (92). This means that VCYT’s stock grew similarly to GERN’s over the last 12 months.

VCYT's P/E Growth Rating (62) in the Biotechnology industry is in the same range as GERN (66). This means that VCYT’s stock grew similarly to GERN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GERNVCYT
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GHTMX13.49N/A
N/A
Goldman Sachs International T/M Eq Instl
EISMX40.33N/A
N/A
Eaton Vance Atlanta Capital SMID-Cap I
RYMCX6.95N/A
N/A
Royce Micro-Cap Consult
BFGIX46.50N/A
N/A
Baron Focused Growth Institutional
TTDAX9.53N/A
N/A
Toews Tactical Defensive Alpha